TELO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Telomir Pharmaceuticals Inc (TELO) is not a good buy for a beginner investor with a long-term focus at this time. The financial performance is weak, with declining net income and EPS, and there are no significant positive catalysts or trading signals to justify an entry. The technical indicators are neutral, and there is no recent news or analyst activity to support a bullish case. Given the lack of strong growth trends or positive sentiment, holding off on this stock is recommended.
The MACD is slightly positive at 0.00906 but contracting, indicating no strong momentum. RSI is neutral at 53.937, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 1.329, with resistance at 1.463 and support at 1.196. Overall, the technical indicators suggest a neutral stance.
NULL identified. There are no recent news updates, no significant insider or hedge fund activity, and no positive financial growth trends.
The company's financial performance is weak, with a YoY decline in net income (-28.88%) and EPS (-40.00%). Additionally, there is no recent congress trading data or analyst activity to provide support for the stock.
In Q4 2025, the company reported no revenue growth (0% YoY), a net income decline of -28.88%, and a 40% drop in EPS. Gross margin remained at 0%. The financials indicate poor performance and lack of growth.
No recent analyst ratings or price target changes are available for TELO.
